Genelux develops cancer immunotherapies based on a modified vaccinia virus that infects and destroys tumor cells. It last closed at $2.17 on Nov 20, down 4.82% on the day. Over the last 12 months GNLX insiders bought $0 of stock on the open market and sold $349K, according to SEC Form 4 filings.
AI Auto Pilots
Is GNLX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold GNLX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on GNLXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
GNLX · as of the Nov 20 close · updated each morning
Moving sideways
The stock sits between its 20 and 50 day averages. It is 22% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 52). The nearest support is the Pivot S1 at $2.06, and the nearest resistance the Pivot at $2.23.
Short trendNeutral
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 9.0%/day
Key levels
$5.8952 week high+171.4%
$2.64200 day average+21.7%
$2.53100 day average+16.6%
$2.35Pivot R1+8.3%
$2.2850 day average+5.1%
$2.27Swing high (Oct 29)+4.6%
$2.23Pivot+2.8%
$2.17Last close
$2.06Pivot S1−5.1%
$2.0120 day average−7.4%
$1.86Swing low (Oct 27)−14.3%
$1.7752 week low−18.4%
Indicators
RSI (14)
52.25
Middle of its range
Neutral
MACD
-0.04
Above its signal line
Bullish
Stochastic
81.9
Near the top of its range
Overbought
ADX (14)
17.0
No clear trend
Williams %R
-37.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
151.1
Oversold below −100, overbought above 100
Overbought
Rate of change
+10.7%
Change over 10 sessions
Bullish
ATR (14)
$0.19
Typical daily range, 9.0% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Downtrend
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityNormal, 17.8%/day
Key levels
$5.8952 week high+171.4%
$2.64200 day average+21.7%
$2.53100 day average+16.6%
$2.35Pivot R1+8.3%
$2.2850 day average+5.1%
$2.27Swing high (Oct 29)+4.6%
$2.23Pivot+2.8%
$2.17Last close
$2.06Pivot S1−5.1%
$2.0120 day average−7.4%
$1.86Swing low (Oct 27)−14.3%
$1.7752 week low−18.4%
Indicators
RSI (14)
40.50
Middle of its range
Neutral
MACD
-0.25
Below its signal line
Bearish
Stochastic
18.8
Near the bottom of its range
Oversold
ADX (14)
20.1
Weak trend
Williams %R
-66.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-104.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−12.8%
Change over 10 sessions
Bearish
ATR (14)
$0.39
Typical daily range, 17.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for GNLX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how GNLX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow GNLX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for GNLXHow many large options trades hit GNLX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in GNLX in the last 90 days.
From SEC Form 4 filings by GNLX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GNLX is in one of them and how their past GNLX trades turned out.
Genelux is a biopharmaceutical company based in Westlake Village, California, that develops cancer treatments built on a modified vaccinia virus. Its lead candidate, Olvi-Vec, is designed to infect and destroy tumor cells while prompting the immune system to attack cancer throughout the body. The company is testing it in ovarian cancer, lung cancer and small cell lung cancer, aiming at patients whose tumors have responded poorly to standard treatments such as chemotherapy. It also operates a manufacturing facility in San Diego and has licensed rights to Olvi-Vec in China to a partner.